Keratolimbal allograft.

PURPOSE OF REVIEW Keratolimbal allograft (KLAL) transplants limbal tissue attached to a corneoscleral carrier from a cadaveric donor to deliver a large number of stem cells to the recipient. The present article will provide a review of KLAL focusing on the recent literature. RECENT FINDINGS Recent findings pertain to tissue selection, immunosuppression and adverse event profiles, and postoperative complications (particularly related to immunologic rejection). SUMMARY KLAL permits the treatment of limbal stem cell deficiency eyes when there is no available living-related or autograft tissue with minimal risk of irreversible toxicity from modern systemic immunosuppression. The prevention of immunologic graft rejection with the use of systemic immunosuppression after KLAL is critical and may require extending systemic immunosuppression treatment longer than previously thought. With vigilant postoperative management, KLAL can allow successful treatment of the most severely diseased eyes.

[1]  E. Holland,et al.  Donor-Derived Conjunctival-Limbal Melanoma After a Keratolimbal Allograft , 2017, Cornea.

[2]  A. Movahedan,et al.  Late Acute Rejection After Allograft Limbal Stem Cell Transplantation: Evidence for Long-Term Donor Survival , 2017, Cornea.

[3]  E. Holland,et al.  Ocular Surface Squamous Neoplasia in a Living-Related Conjunctival Limbal Allograft , 2016, Cornea.

[4]  Clara C. Chan,et al.  Intravenous immunoglobulin for antibody-mediated keratolimbal allograft rejection , 2015, BMJ Case Reports.

[5]  M. Farid,et al.  Ocular Surface Reconstruction With Keratolimbal Allograft for the Treatment of Severe or Recurrent Symblepharon , 2015, Cornea.

[6]  Medi Eslani,et al.  Complications of Keratolimbal Allograft Surgery , 2013, Cornea.

[7]  E. Holland,et al.  Ocular Surface Stem Cell Transplantation Rejection: Incidence, Characteristics, and Outcomes , 2013, Cornea.

[8]  E. Holland,et al.  42 – Keratolimbal Allograft , 2013 .

[9]  E. Holland,et al.  The Modified Cincinnati Procedure: Combined Conjunctival Limbal Autografts and Keratolimbal Allografts for Severe Unilateral Ocular Surface Failure , 2012, Cornea.

[10]  E. Holland,et al.  Systemic Immunosuppression in Ocular Surface Stem Cell Transplantation: Results of a 10-Year Experience , 2012, Cornea.

[11]  N. Nassiri,et al.  Adverse Effects of Systemic Immunosuppression in Keratolimbal Allograft , 2012, Journal of ophthalmology.

[12]  Eui Seok Han,et al.  Long-term outcome and prognostic factor analysis for keratolimbal allografts , 2011, Graefe's Archive for Clinical and Experimental Ophthalmology.

[13]  E. Holland,et al.  The Cincinnati Procedure: Technique and Outcomes of Combined Living-Related Conjunctival Limbal Allografts and Keratolimbal Allografts in Severe Ocular Surface Failure , 2011, Cornea.

[14]  N. Nassiri,et al.  Limbal allograft transplantation using fibrin glue. , 2011, Archives of ophthalmology.

[15]  S. Tseng,et al.  Long-term outcomes of keratolimbal allograft for total limbal stem cell deficiency using combined immunosuppressive agents and correction of ocular surface deficits. , 2009, Archives of ophthalmology.

[16]  R. Malhotra,et al.  Adnexal surgery in patients undergoing ocular surface stem cell transplantation. , 2009, Ophthalmology.

[17]  Cees van Kooten,et al.  Chronic renal allograft rejection: pathophysiologic considerations. , 2005, Kidney international.

[18]  E. Holland,et al.  The Paton Lecture: Ocular Surface Transplantation 10 Years’ Experience , 2004, Cornea.

[19]  E. Holland,et al.  Management of aniridic keratopathy with keratolimbal allograft: a limbal stem cell transplantation technique. , 2003, Ophthalmology.

[20]  S. Daya,et al.  Long-term outcomes of keratolimbal allograft for the treatment of severe ocular surface disorders. , 2002, Ophthalmology.

[21]  C. Foster,et al.  Limbal stem cell transplantation in chronic inflammatory eye disease. , 2002, Ophthalmology.

[22]  M. Mannis,et al.  Living-Related Conjunctival Limbal Allograft , 2002 .

[23]  K. Tsubota,et al.  Association of preoperative tear function with surgical outcome in severe Stevens-Johnson syndrome. , 2000, Ophthalmology.

[24]  E. Holland.  Epithelial transplantation for the management of severe ocular surface disease. , 1997, Transactions of the American Ophthalmological Society.